Stay updated with breaking news from Disease Brain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioArctic: Results from lecanemab confirmatory phase 3 Clarity AD study to be presented at 15th Clinical Trials on Alzheimer's Disease (CTAD) conference - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the efficacy, safety and biomarker results from the Phase 3...
In a new study of Alzheimer's disease, researchers at UC San Francisco have discovered that a relatively unstudied form of the tau protein associated with neurodegeneration may be a means for better diagnosis and treatment of the disease.
Fragmented tau that accumulates in neurons in those with Alzheimer's disease may be a new target for drugs to treat the neurodegenerative disease.
Extreme drowsiness during the day is a common sign of Alzheimer's disease, but what causes it? We now have an answer thanks to a recent study. Even after